Kelly et al. (2010) reported that women treated with paroxetine, a potent CYP2D6 inhibitor, were more likely to die from breast cancer, possibly due to treatment failure as a result of the tamoxifen-paroxetine drug interaction. The gene discussed is CYP2D6; the disease is breast carcinoma.